Gangliosides and Tumor-Associated Ganglioside (TAG) Modulate Receptor-Tyrosine Kinases (RTKs)
Publisher
Springer Singapore
Reference221 articles.
1. Vrijens P, Noppen S, Boogaerts T, Vanstreels E, Ronca R, Chiodelli P, Laporte M, Vanderlinden E, Liekens S, Stevaert A, Naesens L (2019) Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway. J Gen Virol 100(4):583–601 2. König R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, García-Sastre A, Young JA, Palese P, Shaw ML, Chanda SK (2010) Human host factors required for influenza virus replication. Nature 463:813–817 3. Julien S, Bobowski M, Steenackers A, Le Bourhis X, Delannoy P (2013) How do gangliosides regulate RTKs signaling? Cell 2:751–767 4. Oblinger JL, Boardman CL, Yates AJ, Burry RW (2003) Domain-dependent modulation of PDGFRbeta by ganglioside GM1. J Mol Neurosci 20(2):103–114 5. Golard A (1998) Anti-GM3 antibodies activate calcium inflow and inhibit platelet-derived growth factor beta receptors (PDGFβ) in T51B rat liver epithelial cells. Glycobiology 8:1221–1225
|
|